Valuation: Lupin Limited

Market Cap 1,007B 10.53B 9.01B 8.43B 7.72B 14.52B 14.8B 99.75B 38.88B 505B 39.52B 38.66B 1,675B P/E 2027 *
22.9x
P/E 2028 * 21.5x
Enterprise Value 964B 10.07B 8.62B 8.06B 7.39B 13.89B 14.16B 95.43B 37.19B 483B 37.81B 36.98B 1,602B EV / Sales 2027 *
3.18x
EV / Sales 2028 * 2.89x
Free-Float
52.97%
Yield 2027 *
0.58%
Yield 2028 * 0.58%
1 day-0.76%
1 week-2.72%
Current month-8.73%
1 month-9.79%
3 months-3.65%
6 months-1.14%
Current year+4.31%
1 week 2,202.9
Extreme 2202.9
2,265.5
1 month 2,202.9
Extreme 2202.9
2,521.4
Current year 2,072.95
Extreme 2072.95
2,530
1 year 1,881.8
Extreme 1881.8
2,530
3 years 1,061.25
Extreme 1061.25
2,530
5 years 583.05
Extreme 583.05
2,530
10 years 505
Extreme 505
2,530
Manager TitleAgeSince
Chief Executive Officer 58 2013-08-31
Director of Finance/CFO 61 2007-08-12
Compliance Officer - 2024-08-31
Director TitleAgeSince
Director/Board Member 52 2008-10-07
Director/Board Member 58 1996-12-31
Chairman 82 2017-08-10
Change 5-day change 1-year change 3-year change Capi.($)
-0.76%-2.72%+11.93%+106.25% 10.62B
-2.81%+1.98%+76.96%+127.73% 1,141B
-2.21%+2.50%+50.38%+55.01% 659B
-1.56%+5.25%+26.98%+74.39% 470B
+1.20%+1.72%+42.89%+45.78% 366B
-0.61%+1.72%+25.21%+41.34% 302B
+0.32%+3.30%+2.60%+13.42% 254B
-1.95%+4.22%+46.75%+65.66% 239B
-1.10%-1.12%-14.91%-52.66% 207B
-2.82%+5.57%+21.58%+89.04% 183B
Average -0.94%+3.50%+29.04%+56.59% 383.16B
Weighted average by Cap. -0.78%+4.29%+44.33%+70.95%

Financials

2027 *2028 *
Net sales 303B 3.17B 2.71B 2.54B 2.32B 4.37B 4.45B 30.01B 11.7B 152B 11.89B 11.63B 504B 321B 3.35B 2.87B 2.68B 2.46B 4.62B 4.71B 31.78B 12.39B 161B 12.59B 12.32B 533B
Net income 43.72B 457M 391M 366M 335M 630M 642M 4.33B 1.69B 21.93B 1.72B 1.68B 72.67B 46.75B 489M 418M 391M 358M 674M 687M 4.63B 1.8B 23.46B 1.83B 1.79B 77.72B
Net Debt -43.72B -457M -391M -366M -335M -630M -642M -4.33B -1.69B -21.93B -1.72B -1.68B -72.67B -78.59B -821M -703M -657M -603M -1.13B -1.15B -7.78B -3.03B -39.43B -3.08B -3.02B -131B
Logo Lupin Limited
Lupin Limited is a leading Indian pharmaceutical group. Its products are used to treat tuberculosis, diabetes, asthma, cardiovascular diseases, infections, etc. The group's activity is organized around 2 areas: - design and production of generic and brand-name formulations; - production of active pharmaceutical ingredients. At the end of March 2022, the group had 15 production sites India (12), the United States, Mexico and Brazil. Net sales break down geographically as follows: India (39.4%), the United States (34.1%) and other (26.5%).
Employees
26,021
Date Price Change Volume
26-08-20 ₹2,203.10 -0.76% 7,623
26-08-19 ₹2,220.00 -0.22% 10,235
26-08-18 ₹2,225.00 -1.51% 26,965
26-08-17 ₹2,259.20 +1.08% 37,269
26-08-14 ₹2,235.00 -1.15% 34,587
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
2,203.10INR
Average target price
2,513.22INR
Spread / Average Target
+14.08%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LUPIN Stock